Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Apremilast and Moderate to Severe Chronic Hand Dermatitis (CHD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03741933
Recruitment Status : Terminated (The principal investigator left George Washington University and closed the study at their departure.)
First Posted : November 15, 2018
Last Update Posted : November 25, 2019
Sponsor:
Collaborator:
Celgene Corporation
Information provided by (Responsible Party):
Alison Ehrlich, George Washington University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : August 1, 2019
Actual Study Completion Date : August 1, 2019
Publications:
Berg S. Prävalenz von Handekzemen in Heidelberg und weltweit - die Heidelberger Prävalenzstudie im Vergleich mit Ergebnissen aus der Literatur. Dissertation, Heidelberg, 2005